Cargando…

Potent Dengue Virus Neutralization by a Therapeutic Antibody with Low Monovalent Affinity Requires Bivalent Engagement

We recently described our most potently neutralizing monoclonal antibody, E106, which protected against lethal Dengue virus type 1 (DENV-1) infection in mice. To further understand its functional properties, we determined the crystal structure of E106 Fab in complex with domain III (DIII) of DENV-1...

Descripción completa

Detalles Bibliográficos
Autores principales:	Edeling, Melissa A., Austin, S. Kyle, Shrestha, Bimmi, Dowd, Kimberly A., Mukherjee, Swati, Nelson, Christopher A., Johnson, Syd, Mabila, Manu N., Christian, Elizabeth A., Rucker, Joseph, Pierson, Theodore C., Diamond, Michael S., Fremont, Daved H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3990716/ https://www.ncbi.nlm.nih.gov/pubmed/24743696 http://dx.doi.org/10.1371/journal.ppat.1004072

Ejemplares similares

Structural Basis of Differential Neutralization of DENV-1 Genotypes by an Antibody that Recognizes a Cryptic Epitope
por: Austin, S. Kyle, et al.
Publicado: (2012)

The Development of Therapeutic Antibodies That Neutralize Homologous and Heterologous Genotypes of Dengue Virus Type 1
por: Shrestha, Bimmi, et al.
Publicado: (2010)

Development of a Highly Protective Combination Monoclonal Antibody Therapy against Chikungunya Virus
por: Pal, Pankaj, et al.
Publicado: (2013)

Mechanism of differential Zika and dengue virus neutralization by a public antibody lineage targeting the DIII lateral ridge
por: Zhao, Haiyan, et al.
Publicado: (2019)

Structural basis of West Nile virus neutralization by a therapeutic antibody
por: Nybakken, Grant E., et al.
Publicado: (2005)

SARS-CoV-2 neutralising antibodies after bivalent versus monovalent booster
por: Wang, Qian, et al.
Publicado: (2023)

Bivalent Brain Shuttle Increases Antibody Uptake by Monovalent Binding to the Transferrin Receptor
por: Hultqvist, Greta, et al.
Publicado: (2017)

Binding of Monovalent and Bivalent Ligands by Transthyretin Causes Different Short- and Long-Distance Conformational Changes
por: Corazza, Alessandra, et al.
Publicado: (2019)

Cost-effectiveness of bivalent versus monovalent vaccines against hand, foot and mouth disease
por: Liu, D., et al.
Publicado: (2019)

Preliminary Study on the Host Response to Bivalent and Monovalent Autogenous Vaccines against Mycoplasma agalactiae in Dairy Sheep
por: Hussein, Hany A., et al.
Publicado: (2022)

Capturing a Flavivirus Pre-Fusion Intermediate
por: Kaufmann, Bärbel, et al.
Publicado: (2009)

The Type-Specific Neutralizing Antibody Response Elicited by a Dengue Vaccine Candidate Is Focused on Two Amino Acids of the Envelope Protein
por: VanBlargan, Laura A., et al.
Publicado: (2013)

Comparative Effectiveness of COVID-19 Bivalent Versus Monovalent mRNA Vaccines in the Early Stage of Bivalent Vaccination in Korea: October 2022 to January 2023
por: Kim, Ryu Kyung, et al.
Publicado: (2023)

Effect of monovalent and bivalent live attenuated vaccines against QX-like IBV infection in young chickens
por: Yang, Chen-Yu, et al.
Publicado: (2023)

Dengue and Zika Virus Cross-Reactive Human Monoclonal Antibodies Protect against Spondweni Virus Infection and Pathogenesis in Mice
por: Salazar, Vanessa, et al.
Publicado: (2019)

Immunogenicity and Efficacy of Monovalent and Bivalent Formulations of a Virus-Like Particle Vaccine against SARS-CoV-2
por: Resch, Matthew D., et al.
Publicado: (2022)

Enhancing the therapeutic activity of hyperimmune IgG against chikungunya virus using FcγRIIIa affinity chromatography
por: Fox, Julie M., et al.
Publicado: (2023)

Comparison of bivalent and monovalent SARS-CoV-2 variant vaccines: the phase 2 randomized open-label COVAIL trial
por: Branche, Angela R., et al.
Publicado: (2023)

Effective Protection Induced by a Monovalent DNA Vaccine against Dengue Virus (DV) Serotype 1 and a Bivalent DNA Vaccine against DV1 and DV2 in Mice
por: Zheng, Xiaoyan, et al.
Publicado: (2017)

Design of Monovalent and Chimeric Tetravalent Dengue Vaccine Using an Immunoinformatics Approach
por: Dixit, Neeraj Kumar
Publicado: (2021)

Cross-variant protection against SARS-CoV-2 infection in hamsters immunized with monovalent and bivalent inactivated vaccines
por: Ye, Zi-Wei, et al.
Publicado: (2022)

A DFT/PCM Study on the Affinity of Salinomycin to Bind Monovalent Metal Cations
por: Dudev, Todor, et al.
Publicado: (2022)

Mouse and Human Monoclonal Antibodies Protect against Infection by Multiple Genotypes of Japanese Encephalitis Virus
por: Fernandez, Estefania, et al.
Publicado: (2018)

Affinity maturation is required for pathogenic monovalent IgG4 autoantibody development in myasthenia gravis
por: Fichtner, Miriam L., et al.
Publicado: (2020)

Structure and Intracellular Targeting of the SARS-Coronavirus Orf7a Accessory Protein
por: Nelson, Christopher A., et al.
Publicado: (2005)

In silico prediction of monovalent and chimeric tetravalent vaccines for prevention and treatment of dengue fever
por: Subramaniyan, Vijayakumar, et al.
Publicado: (2018)

A molecular understanding of alphavirus entry
por: Holmes, Autumn C., et al.
Publicado: (2020)

Dynein and Dynactin Leverage Their Bivalent Character to Form a High-Affinity Interaction
por: Siglin, Amanda E., et al.
Publicado: (2013)

Phase 1 trial to model primary, secondary, and tertiary dengue using a monovalent vaccine
por: Odio, Camila D., et al.
Publicado: (2023)

Monovalent Omicron COVID-19 vaccine triggers superior neutralizing antibody responses against Omicron subvariants than Delta and Omicron bivalent vaccine
por: Li, Wanting, et al.
Publicado: (2023)

Genotypic Differences in Dengue Virus Neutralization Are Explained by a Single Amino Acid Mutation That Modulates Virus Breathing
por: Dowd, Kimberly A., et al.
Publicado: (2015)

prM-reactive antibodies reveal a role for partially mature virions in dengue virus pathogenesis
por: A. Dowd, Kimberly, et al.
Publicado: (2023)

Development of ultra-high affinity bivalent ligands targeting the polo-like kinase 1
por: Tsuji, Kohei, et al.
Publicado: (2022)

Assessment of bivalent and tetravalent dengue vaccine formulations in flavivirus-naïve adults in Mexico
por: Dayan, Gustavo H, et al.
Publicado: (2014)

Beyond Neutralizing Antibody Levels: The Epitope Specificity of Antibodies Induced by National Institutes of Health Monovalent Dengue Virus Vaccines
por: Swanstrom, Jesica A, et al.
Publicado: (2019)

A Therapeutic Antibody against West Nile Virus Neutralizes Infection by Blocking Fusion within Endosomes
por: Thompson, Bruce S., et al.
Publicado: (2009)

The mechanistic basis of protection by non-neutralizing anti-alphavirus antibodies
por: Earnest, James T., et al.
Publicado: (2021)

Studies toward bivalent κ opioids derived from salvinorin A: heteromethylation of the furan ring reduces affinity
por: Munro, Thomas A, et al.
Publicado: (2013)

Microtitration of Rubella Virus in Monovalent Vaccinal Products
por: Esna-Ashari, F, et al.
Publicado: (2011)

A Dual Swine Challenge With Porcine Circovirus Type 2 (PCV2) and Mycoplasma hyopneumoniae Used to Compare a Combination of Mixable Monovalent PCV2 and Monovalent M. hyopneumoniae Vaccines With a Ready-to Use PCV2 and M. hyopneumoniae Bivalent Vaccine
por: Yang, Siyeon, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_tq6cr1711natfkr34h36b9k555